FUNDED PROJECTS OF OUR VACCINE STUDY GROUP
|
1 |
Project Title: Developing Diagnostic Kits, Drug Formulations and Vaccines Against HPV and Influenza-borne Infections that Mostly Threaten Public Health in Our Country and in the World Project date: 2021-2025 Organization supporting the project: TÜBİTAK 1004 (Project No: 20AG005) Project budget: 2.455.000 TL The project continues. |
|
2 |
Project title: Development of a DNA and recombinant protein vaccine strategy effective for all three stages of Toxoplasma gondii Project date: 2021 - 2023 Organization supporting the project: Ege University Rectorate (Project No: TOA-2021-22890) Project budget: 321.790 TL The project continues. |
|
3 |
Project title: Development of a Nanoadjuvant DNA and Recombinant Protein Vaccine Model Against Toxoplasma gondii Project date: 2019-2020 Organization supporting the project: TÜBİTAK 1002 (Project No: 119S367) Project budget: 45.000 TL The project has been completed. |
|
4 |
Project title: Development of “Animal Rec-ELISA” kit to diagnose toxoplasmosis in domestic and stray cats Project date: 2015-2017 Organization supporting the project: KOSGEB (Approval code: 2015-691-1) Project budget: 179.060 TL The project has been completed. |
|
5 |
Project title: Development of nanotechnological vaccine against COVID-19 Project date: 2021 - 2023 Organization supporting the project: Ege University Rectorate (Project No: FDK-2021-22333) Project budget: 119.660 TL The project is ongoing |
|
6 |
Project title: COVID-19 Turkey Platform, Rapid DNA Vaccine Development Against COVID-19 Project date: 2020-2022 Organization supporting the project: TÜBİTAK 1004 (Project No: 18AG020) Project budget: 1.500.000 TL The project continues. |
|
7 |
Project title: Development of “Fast HotShot Crypto-LAMP” kit to diagnose cryptosporidiosis in calves Project date: 2020-2022 Organization supporting the project: KOSGEB (Approval code: 2020-682-3) Project budget: 780.000 TL The project continues. |
|
8 |
Project Title: Development of a Country-Specific Peptide-ELISA that can Serotype Toxoplasma gondii Infection: Investigation of Serotype in Small Group Toxoplasmosis Patients Project date: 2018-2020 Organization supporting the project: Katip Çelebi University (Project No: 2018-ÖNAP-TIPF-0006) Project budget: 83.147 TL The project has been completed. |
|
9 |
Project Title: Development of Anti-Apopotic DNA Vaccine Based Immunotherapy Model Against Breast Cancer Project date: 2016-2019 Organization supporting the project: Ege University Rectorate (Project No: 2016TIP082) Project budget: 38.455 TL The project has been completed. |
|
10 |
Project Title: Development of High Cationic Nanotechnological Adjuvant Systems and Demonstration of Efficiency in Both Breast Cancer DNA Vaccine Models Project date: 2016-2019 Organization supporting the project: Ege University Rectorate (Project No: 2016MÜH018) Project budget: 10.000 TL The project has been completed. |
|
11 |
Project title: Continuous Cell Line Development for Production of Recombinant Anti-HER2 Antibody Project date: 2016-2019 Organization supporting the project: Ege University Rectorate (Project No: 2016MÜH110) Project budget: 10.498 TL The project has been completed. |
|
12 |
Project Title: Investigation of the efficacy of apoptosis-inhibiting DNA vaccine model developed against Infectious Microorganisms Project date: 2010-2011 Organization supporting the project: TÜBİTAK TOVAG 1002 (Project No: 110O809) Project budget: 24.950 TL The project has been completed. |
|
13 |
Project Title: Development of Adjuvanted Multivalent Recombinant Protein Vaccine Against Toxoplasmosis Project date: 2010-2013 Organization supporting the project: TÜBİTAK SBAG 1001 (Project No: 110S200) Project budget: 358.533 TL The project has been completed. |
|
14 |
Project Title: Immunogenic Anti-Sporozoite Vaccine Candidate Against Toxoplasmosis Project date: 01/02/2008-01/02/2010 Organization supporting the project: TÜBİTAK SBAG 1001 (Project No:107S359) Project budget: 105.000 TL The project has been completed. |
|
15 |
Project Title: Toxoplasma Reference Center Advanced Research Applications: Investigation of Recombinant SporoSAG and BAG1 Proteins Expressed by Rosetta 2 (DE3) pLysS Cells in the Diagnosis of Early Acute Toxoplasmosis. Project date: 01/12/2006-01/12/2009 The organization supporting the project: Ege University Rectorate Research Fund Accounting (Project No: 2007TIP015). Project budget: 156.000 TL The project has been completed. |
